Abstract
The processes of tissue regeneration and repair, the cyclical proliferation of the nutrient-rich endometrial lining in preparation for implantation of the fertilized egg; and the complex developmental program that characterizes embryogenesis are biological processes that are strictly dependent on the rapid yet temporary ingrowth of new capillary blood vessels. In contrast, disorders such as neoplasia, proliferative vascular lesions, rheumatoid arthritis and psoriasis, and glaucoma are all characterized by disregulated angiogenesis. The mechanisms underling inappropriate neovascularization have been the subject of considerable investigation. Although there is ample evidence implicating the “overproduction” of normal and/or aberrant forms of angiogenic mediators in the pathogenesis of several well characterized disorders, only recently has attention been given to the role of naturally occurring inhibitors of angiogenesis and the consequences that result from a deficiency in the production of one or more of these “angiostatic” mediators (Moses and Langer, 1991a; Bouck, 1990 and 1993; DiPietro and Polverini, 1993, in press). This report will describe recent studies that support the assertion that angiogenesis is a process that is dependent upon the coordinate production of growth stimulatory and inhibitory molecules and that any disruption in this finely tuned regulatory circuit can result in the development of a number of diseases now classified as “angiogenesisdependent”.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bader, S.A., Fasching, C., Brodeur, G.M., and Stanbridge, E.J., Dissocoation of suppression of tumorigenicity and differentiation in vitro effected by transfer of a single human chromosome into neuroblastoma cells. Cell Growth Differ. 2: 245.
Blood, C.H., and Zetter, B.R., 1990, Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochim. Biophys. Acta 1032: 89
Bornstein, P., 1992, Thrombospondins: structure and regulation of expression. FASEB Jr. 6: 3290.
Bouck, N., 1990, Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 2, 179.
Bouck, N., Angiogenesis: a mechanism by which oncogenes and tumor suppressor genes regulate tumorigenesis, in “ Oncogenes and Tumor Suppressor Genes” C.C. Benz and E.T. Liu, eds, Kluwer Academic Publishers, Boston
Bouck, N. P., Stoler, A. and Polverini, P. J., 1986, Coordinate control of anchorage independence, actin cytoskeleton and angiogenesis by human chromosome 1 in hamster-human hybrids. Cancer Res. 46: 5101.
Brem, H., and Folkman, J., 1975, Inhibition of tumor angiogenesis mediated by cartilage. J. Exp. Med. 141: 427.
Brem, S., Preis, I., Langer, R., Folkman, J., and Patz, A., 1977, Inhibition of neovascularization by an extract derived from vitreous. Am. J. Ophthalmol. 84: 323.
Cozzolino, F., Torcia, M., Aldinucci, D., Ziche, M., Almerigogna, F., Bani, D., and Stern, D.M., 1990, Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc. Natl. Acad. Sci. USA., 87: 6487.
Crum, R., Sazbo, S., and Folkman, J., 1985, A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230: 1375.
DiPietro, L. A., and Polverini, P.J., 1993, Role of the macrophage in the positive and negative regulation of wound neovascularization, Behring Inst. Mitt., (in press)
DiPietro, L. A., Nebgen, D. R., and Polverini, P.J., [submitted for publication (a)]. Down-regulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis
DiPietro, L. A., and Polverini, P. J., 1993, Angiogenic macrophages produce the angiogenic modulator thrombospondin 1. Am. J. Pathol. in press
Eisenstein, R., Kuettner, K.E., Neopolitan, C., Sobel, L.W., and Sorgente, N., 1975, The resistance of certain tissues to invasion III. Cartilage extracts inhibit the growth of fibroblasts and endothelial cells in culture. Am. J. Pathol. 81: 337.
Engerman R.L., Pfaffenbach, D., and Davis, M.D., 1967, Cell turnover of capillaries. Lab. Invest. 17: 738.
Folkman, J., 1972, Angiogenesis in psoriasis: Therapeutic implications. J. Invest. Dermatol. 59: 40.
Folkman, J., and Klagsbrun, M., 1987, Angiogenic factors. Science 235: 442.
Folkman, J., Weisz, P. B., Joullie, M. M., Li, W. W., and Ewing, W. R., 1989, Control of angiogenesis wiyh systemic heparin substitutes. Scienec 243: 1490.
Frazier, W. A., 1987, Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J. Cell Biol. 105: 625.
Frazier, W. A., 1991, Thrombospondin. Curr. Opinions in Cell Biol. 3: 792.
Goldfarb, M., 1990, The fibroblast growth factor family. Cell Growth Differ. 1: 439.
Good, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., and Bouck, N. P., 1990, A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87: 6624.
Grant, D. K., Tashiro, K-I., Segui-Real, B., Yamada, Y., Martin, G. R., and Kleinman, H. K., 1989, Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58: 933.
Haynes, W. L., Proia, A. D., and Klintworth, G. K., 1989, Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest. Ophthalmol Visual Sci. 30: 1588.
Hogg, P.J., Stenflo, J., and Mosher, D. F., 1992, Thrombospondin is a slow tight-binding inhibitor of plasmin. Biochemistry 31: 265.
Huang, H-J.S., Yee, J-K., Shew, J-Y., Chen, P-L., Bookstein, R., Friedman, T., Lee, E.YH.P., and Lee, W-H., 1988, Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242: 1563.
Ingber, D., and Folkman, J., 1988, Inhibition of angiogenesis through modulation of collagen metabolism. Lab. Invest. 59: 44.
Inoue, K., Korenaga, H., Tahnaka, N. G., Sakamoto, N., and Shizuo, K., 1988, The sulfated polysaccharide-peptidoglycan complex potently inhibits embryonic angiogenesis and tumor growth in the presence of cortisone acetate. Carbohydr. Res. 181: 135.
Iruela-Arispe, M., Bornstein, P., and Sage, H., 1991, Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl. Acad. Sci. USA 88: 5026.
Jaffe, E. A., Ruggiero, J. T., and Falcone D. J., 1985, Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65: 79.
Klagsbrun, M., and D’Amore P.A., 1991, Regulators of angiogenesis. Annu. Rev. Physiol. 53: 217.
Klagsbrun, M., and Folkman, J., 1990, Peptide Growth Factors and Their Receptors II, in: “Angiogenesis. Handbook of Experimental Pharmacology, Vol., 95/II”, p. 549–586. M.B. Sporn and A.B. Roberts, (Eds.) Springer-Verlag, Berlin, Heildelberg, Germany.
Koch, A. E., Polverini, P. J., and Leibovich, S. J., 1986, Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arth. Rheum. 29: 471.
Koch, A. E.,Polverini, P.J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V.M., Elner, S.G., and Strieter, R.M., 1992, Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science 258: 1798.
Langer, R., Brem, H., Falterman, K., Klein, M., and Folkman, J., 1976, Isolation of a cartilage factor that inhibits tumor neovascularization Science 193: 70.
Lawler, J., 1986, The structural and functional properties of thrombospondin. Blood 67: 1197.
Lee, A., and Langer, R., 1983, Shark cartilage contains inhibitors of tumor angiogenesis. Science 221: 1185.
Lutty, G. A., Thompson, D. C., Gallup, J. Y., Mello, R. J., Patz, A., and Fenselau, A., 1983, Vitreous: an inhibitor of retinal extract-induced neovascularization. Invest. Ophthalmol. Vis. Sci. 24: 52.
Lynch, N. R., Castes, M., Astoin, M., and Salomon, J. C., 1978, Mechanisms of inhibition of tumor growth by asprin and indomethacin. Br. J. Cancer 38: 503.
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., and Sharpe, R. J., 1990, Inhibition of angiogenesis by recombinant human platelt factor-4 and related peptides. Science 247: 77.
Mansfield, P. J., Boxer, L. A., and Suchard, S. J., 1990, Thrombospondin stimulates motility of human neutrophils. J. Cell Biol. 111: 3077.
Moroco, J.R., Solt, D.B., and Polverini, P.J., 1990, Sequential loss of suppressor genes for three specific functions during in vivo carcinogenesis. Lab. Invest. 63: 298.
Moses, M.A., and Langer, R., 1991a, Inhibitors of angiogenesis. Biotechnology 9: 630.
Moses, M. A., and Langer, R., 1991b, A metalloproteinase inhibitor as an inhibitor of neovascularization. J. Cell. Biochem. 47: 230.
Nathan, C. F. (1987) Secreted products of macrophages. J. Clin. Invest. 79, 319–26.
Nickoloff, B. J., Mitra, R. S., Varani, J., Dixit, V. M., and Polverini, P. J. (submitted for publication) Psoriatic keratinocyte induced angiogenesis is inhibited by hrombospondin.
O’Shea, K. S., and Dixit, V. M., 1988, Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J. Cell Biol. 107: 27–37.
Oikawa, T., Hirotani, K., Nakamura, O., Shudo, K., Hiragun, A., and Iwaguchi, T., 1989, A highly potent antiangiogenic activity of retinoids. Cancer Lett. 48: 157
Orchard, P. J., Smith, C. M. II, Woods, W. G., Day, D. L., and Dehner, L. P., 1989, Treatment of hemangioendotheliomas with alpha interferon. The Lancet 2: 565.
Pauli, B., Memoli, V., and Kuttner, K., 1981, Regulation of tumor invasion by cartilage-derived anti-invasive factor in vitro. J. Natl. Cancer Inst. 67: 65.
Peterson, H-I., 1986, Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors. Anticancer Res. 6: 251.
Polverini, P. J., 1989, Macrophage-induced Angiogenesis: A review; in, “Macrophage- Derived Cell Regulatory Factors”, C. Sorg, ed., S. Karger, Basel, pp. 54
Rastinejad, F., Polverini, P. J. and Bouck N. P., 1989, Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56: 345.
Robin, J. B., Regis-Pacheco, L. F., Kash, R. L., and Schanzlin, D. J., 1985, The histopathology of of corneal neovascularization, inhibitor effects. Arch Ophthalmol. 103: 284.
Sage, H., and Bornstein, P., 1982, Endothelial cells from umbilical vein and a hemangioendothelioma secrete basement membrane largely to the exclusion of interstitial procollagens. Arteriosclerosis 2: 27.
Sage, H., and Bornstein, P., 1991, Extracellular proteins that modulate cell-matrix interactions. J Biol. Chem. 266: 14831.
Savill, J., Hogg, N., and Haslett, C., 1991, Macrophage vitronectin receptor, CD36, and thrombospondin cooperate in recognition of neutrophils undergoing programmed cell death. Chest 99: 65.
Shapiro, R., and Valee, B. L., 1987, Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc. Natl. Acad. Sci. 84: 22–38.
Sidky, Y. A., and Borden, E. C., 1987, Inhibition of angiogenesis by interferons: effects on tumor-and lymphocyte-induced vascular responses. Cancer Res. 47: 51–55.
Silverstein, R. L., and Nachman, R. L., 1987, Thrombospondin binds to monocytes and macrophages and mediates platelet-monocyte adhesion. J. Clin. Invest. 79: 867.
Strieter, R. M., Kunkel, S. L., Elner, V. M., Martonyi, C. L., Koch, A. E., Polverini, P. J., and Elner, S. G., 1992, Interleukin-8 a corneal factor that induces neovascularization. Am. J. Pathol. 141: 1279.
Tannock, I. F., and Hayashi, S., 1972, The proliferation of capillary endothelial cells. Cancer Res. 32: 77.
Taylor, C. W., and Weiss, J. B., 1985, Partial purification of a 5.7k glycoprotein from bovine vitreous which inhibits both angiogenesis and collagenase activity. Biochem and Biophys. Res. Commun. 133: 911.
Taylor, S., and Folkman, J., 1982, Protamine is an inhibitor of angiogenesis. Nature 297: 307.
Thomas, K.A., 1988, Transforming potential of fibroblast growth factor genes. Trends in Biochem. Sci. 13: 327.
Tolsma, S.S., Volpert, O.V., Good, D.J., Frazier, W.A., Polverini, P.J., and Bouck, N., 1993, Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity, J. Cell Biol. in press.
West, D. C., and Kumar, S., 1989, Hyaluronan and Angiogenesis, in, The Biology of Hyaluronan ( Ciba Foundation Symp.) Wiley, Chichester, pp 143.
White, C. W., Wolf, S. J., Korones, D. N., Sondheimer, H. M., Tosi, M. F., and Yu, A., 1991, Treatment of childhood angiomatous diseases with recombinant interferon alpha. J. Pediatr. 118: 59.
Woltering, E. A., Barrie, R., O’Dorisio, T. M., Arce, D., Ure, T., Cramer, A., Holmes, D., Robertson, J., and Fassler, J., 1991, Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. J. Surg. Res. 50: 245.
Ziche, M., Jones, J., and Gullino, P. M., 1982, Role of prostaglandin El and copper in angiogenesis. J. Natl. Cancer Inst. 69: 475.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Polverini, P.J. (1994). Inhibitors of Neovascularization: Critical Mediators in the Coordinate Regulation of Angiogenesis. In: Maragoudakis, M.E., Gullino, P.M., Lelkes, P.I. (eds) Angiogenesis. NATO ASI Series, vol 263. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9188-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9188-4_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9190-7
Online ISBN: 978-1-4757-9188-4
eBook Packages: Springer Book Archive